| | May 20197UTLOOK Healthcare Tech Let Novotech help you access the untapped benefits of the Asia Pacific regionThe availability of large patient pools and access to some of the most engaged investigators in the world make Asia a key region to accelerate later phase development at lower costs.While Australia's fast approval timelines and lucrative R&D cash refund scheme make it a preferred destination for early stage research.With on the ground operations in 11 countries in the Asia Pacific region, Novotech is the largest independent full service clinical trial partner and recipient of Frost & Sullivan's 2017 Asia Pacific Biotech CRO Of The Year award.8%13%72%7%85% of clients are located in the United States or EuropeUSnovotech-cro.comEUAsiaANZ69% of clients are repeat customers69%
< Page 6 | Page 8 >